DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p

Table 1 Relationship between DNAH17-AS1 expression and clinicopathological characteristics of pancreatic carcinoma patients

Characteristic	Cases	DNAH17-AS1		P value
		High	Low
Age (yr)				0.82
≥ 60	34	21	13
< 60	44	30	14
Gender				0.63
Male	32	18	14
Female	46	33	13
Differentiation				0.004c
Well	52	36	16
Moderate-Poor	26	15	11
TNM stage				0.001c
I-II	58	40	18
III-IV	20	11	9
Lymph node metastasis				0.01a
No	59	42	17
Yes	19	9	10

Statistical analyses were performed by the χ² test.

^aP < 0.05 was considered significant and

^cP < 0.05 was considered extremely significant.